Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPOXY-IMR: Oxygen in Elective PCI
NCT03369184Phase 3Terminated
- Sponsor
- Karolinska Institutet
- Start
- Jan 2018
- Primary completion
- May 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of oxygen in coronary artery disease (CAD) (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Index of Microcirculatory Resistance at 1 hour. Started Jan 2018; status: terminated.
02
Drugs
oxygen
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03369184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03369184.